Fresenius Medical Care (FMS) said Tuesday that it targets to reach mid-teens percentage in operating income margins by 2030 through its FME Reignite strategy.
The company said it has estimated 1.05 billion euros ($1.21 billion) in sustainable savings by the end of 2027 from its extended FME25 program, which it expects to help support its targeted operating income margins.
Fresenius' chief financial officer, Martin Fischer, said the company plans to allocate 800 million euros to 1 billion euros for capital expenditures annually for 2025 to 2030 to invest in its core business.
Additionally, Fresenius said it is starting a new share buyback program this year, with initial share repurchases of 1 billion euros over two years.
Shares of Fresenius were down more than 3% in recent premarket activity Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.